Israeli bio-insecticide startup secures $6.1m series A
Ibi Ag develops bio-insecticides using single-domain antibody technology from the pharmaceutical sector...Read More
Ibi Ag develops bio-insecticides using single-domain antibody technology from the pharmaceutical sector...Read More